Oguzhan Atay is the Co-Founder and CEO of BillionToOne, a precision diagnostics company advancing molecular testing through its proprietary molecular counting platform. The company is transforming disease detection in areas like non-invasive prenatal screening and liquid biopsy by accurately quantifying biological molecules.
Oguzhan holds a Ph.D. in Systems Biology from Stanford, where he applied machine learning and mathematical modeling to cellular biology. He also earned a degree in Molecular Biology from Princeton, with minors in Computer Science, Physics, and Applied Mathematics.
Get the latest from The Biotech Startups Podcast delivered straight to your inbox. Subscribe for weekly updates on new episode.